AI assistant
Instil Bio, Inc. — Director's Dealing 2025
Sep 12, 2025
33728_dirs_2025-09-12_aa097048-19d2-4cc4-8ca5-41ad4581bd8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2025-09-10
Reporting Person: Laumas Sandeep (CFO and CBO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-10 | Common Stock | M | 17000 | $11.60 | Acquired | 17000 | Direct |
| 2025-09-10 | Common Stock | M | 13000 | $12.68 | Acquired | 30000 | Direct |
| 2025-09-10 | Common Stock | S | 17539 | $23.04 | Disposed | 12461 | Direct |
| 2025-09-10 | Common Stock | S | 12461 | $23.88 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-09-10 | Employee Stock Option (right to buy) | $11.60 | M | 17000 | Disposed | 2034-02-09 | Common Stock (17000) | Direct |
| 2025-09-10 | Employee Stock Option (right to buy) | $12.68 | M | 13000 | Disposed | 2033-01-07 | Common Stock (13000) | Direct |
Footnotes
F1: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $22.70 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
F2: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
F3: Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on February 10, 2025 with the remainder vesting in substantially equal monthly tranches thereafter.
F4: Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on January 8, 2024 with the remainder vesting in substantially equal monthly tranches thereafter.